Literature DB >> 10941218

Galalpha(1,3)Gal epitope in porcine small intestinal submucosa.

T B McPherson1, H Liang, R D Record, S F Badylak.   

Abstract

Small intestinal submucosa (SIS) is a naturally occurring, acellular biomaterial derived from porcine jejunum, which promotes constructive tissue remodeling when applied as a xenogeneic graft material. Galactosyl-alpha(1,3)galactose (Gal) is a cell-associated epitope responsible for hyperacute rejection of porcine whole-organ xenografts in primates. Because SIS is harvested from porcine tissue, it may contain the Gal epitope. The goals of this study were to determine if Gal is present in SIS and, if it is present, to determine if human serum complement can be activated in vitro following exposure to porcine-derived SIS. SIS was probed for Gal by immunohistochemical methods and by lectin-peroxidase staining. SIS stained strongly positive with human serum, which contains naturally occurring antibodies to Gal, followed by anti-immunoglobulin G (IgG) or anti-IgM peroxidase conjugate. Blocking with the lectin I-B(4), which is specific for the Gal epitope, decreased the intensity of staining. Exposure of SIS to alpha-galactosidase reduced staining to negligible amounts. The Gal epitope is distributed transmurally throughout the SIS material. Subtyping of the immunoglobulins that bind to SIS showed that IgG(2) is the major immunoglobulin of human plasma that binds to SIS. SIS did not activate complement in vitro as measured by radioimmunoassay for C3a.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10941218     DOI: 10.1089/10763270050044416

Source DB:  PubMed          Journal:  Tissue Eng        ISSN: 1076-3279


  30 in total

1.  Biologic augmentation of rotator cuff repair.

Authors:  Scott R Montgomery; Frank A Petrigliano; Seth C Gamradt
Journal:  Curr Rev Musculoskelet Med       Date:  2011-12

2.  Novel extra cellular-like matrices to improve human ovarian grafting.

Authors:  Ronit Abir; Dana Stav; Yossi Taieb; Rinat Gabbay-Benziv; Moria Kirshner; Avi Ben-Haroush; Enrique Freud; Shifra Ash; Isaac Yaniv; Michal Herman-Edelstein; Benjamin Fisch; Yoel Shufaro
Journal:  J Assist Reprod Genet       Date:  2020-07-24       Impact factor: 3.412

Review 3.  Immune response to biologic scaffold materials.

Authors:  Stephen F Badylak; Thomas W Gilbert
Journal:  Semin Immunol       Date:  2008-02-20       Impact factor: 11.130

4.  Quantification of DNA in biologic scaffold materials.

Authors:  Thomas W Gilbert; John M Freund; Stephen F Badylak
Journal:  J Surg Res       Date:  2008-03-13       Impact factor: 2.192

5.  Assembly and testing of stem cell-seeded layered collagen constructs for heart valve tissue engineering.

Authors:  Mary E Tedder; Agneta Simionescu; Joseph Chen; Jun Liao; Dan T Simionescu
Journal:  Tissue Eng Part A       Date:  2010-09-06       Impact factor: 3.845

Review 6.  Perspectives on whole-organ assembly: moving toward transplantation on demand.

Authors:  Alejandro Soto-Gutierrez; Jason A Wertheim; Harald C Ott; Thomas W Gilbert
Journal:  J Clin Invest       Date:  2012-11-01       Impact factor: 14.808

Review 7.  Immunological challenges and therapies in xenotransplantation.

Authors:  Marta Vadori; Emanuele Cozzi
Journal:  Cold Spring Harb Perspect Med       Date:  2014-04-01       Impact factor: 6.915

8.  Graft-specific immune tolerance is determined by residual antigenicity of xenogeneic extracellular matrix scaffolds.

Authors:  Ailsa J Dalgliesh; Mojtaba Parvizi; Manuela Lopera-Higuita; Jeny Shklover; Leigh G Griffiths
Journal:  Acta Biomater       Date:  2018-08-18       Impact factor: 8.947

Review 9.  Factors influencing the long-term behavior of extracellular matrix-derived scaffolds for musculoskeletal soft tissue repair.

Authors:  Christopher R Rowland; Dianne Little; Farshid Guilak
Journal:  J Long Term Eff Med Implants       Date:  2012

10.  Functional tissue engineering of ligament healing.

Authors:  Shan-Ling Hsu; Rui Liang; Savio Ly Woo
Journal:  Sports Med Arthrosc Rehabil Ther Technol       Date:  2010-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.